The role of radiation therapy in the treatment of metastatic castrate-resistant prostate cancer
- PMID: 26161144
- PMCID: PMC4485416
- DOI: 10.1177/1756287215576647
The role of radiation therapy in the treatment of metastatic castrate-resistant prostate cancer
Abstract
In the setting of castrate-resistant prostate cancer, patients present with a variety of symptoms, including bone metastases, spinal cord compression and advanced pelvic disease. Fortunately, a variety of radiotherapeutic options exist for palliation. This article focuses on these options, including both external beam radiotherapy and radiopharmaceuticals.
Keywords: bone metastases; hemi-body radiotherapy; palliative radiotherapy; prostate cancer; radiopharmaceuticals; radium 223.
Conflict of interest statement
Similar articles
-
Integrating bone targeting radiopharmaceuticals into the management of patients with castrate-resistant prostate cancer with symptomatic bone metastases.Curr Treat Options Oncol. 2015 Mar;16(3):325. doi: 10.1007/s11864-014-0325-1. Curr Treat Options Oncol. 2015. PMID: 25777571 Review.
-
Palliative radiotherapy for prostate cancer.Oncology (Williston Park). 2014 Apr;28(4):306-12. Oncology (Williston Park). 2014. PMID: 24839802 Review.
-
Use of strontium-89 in endocrine-refractory prostate cancer metastatic to bone. Provincial Genitourinary Cancer Disease Site Group.Cancer Prev Control. 1998 Apr;2(2):79-87. Cancer Prev Control. 1998. PMID: 9765768
-
Radiation for Treatment of Painful Bone Metastases.Hematol Oncol Clin North Am. 2018 Jun;32(3):459-468. doi: 10.1016/j.hoc.2018.01.008. Epub 2018 Mar 17. Hematol Oncol Clin North Am. 2018. PMID: 29729781 Review.
-
Clinical experience with radium-223 in the treatment of patients with advanced castrate-resistant prostate cancer and symptomatic bone metastases.Ther Adv Urol. 2016 Jun;8(3):175-80. doi: 10.1177/1756287216629870. Epub 2016 Feb 25. Ther Adv Urol. 2016. PMID: 27247627 Free PMC article. Review.
Cited by
-
MicroRNA-125a-5p regulates cancer cell proliferation and migration through NAIF1 in prostate carcinoma.Onco Targets Ther. 2015 Dec 17;8:3827-35. doi: 10.2147/OTT.S92314. eCollection 2015. Onco Targets Ther. 2015. PMID: 26719710 Free PMC article.
-
miR-20b promotes cellular proliferation and migration by directly regulating phosphatase and tensin homolog in prostate cancer.Oncol Lett. 2017 Dec;14(6):6895-6900. doi: 10.3892/ol.2017.7041. Epub 2017 Sep 25. Oncol Lett. 2017. PMID: 29163708 Free PMC article.
-
Assessment of Radiation Induced Therapeutic Effect and Cytotoxicity in Cancer Patients Based on Transcriptomic Profiling.Int J Mol Sci. 2016 Feb 19;17(2):250. doi: 10.3390/ijms17020250. Int J Mol Sci. 2016. PMID: 26907258 Free PMC article.
-
Current concepts and trends in the treatment of bone metastases in patients with advanced prostate cancer.Asian J Androl. 2017 Dec 29;21(1):12-8. doi: 10.4103/aja.aja_59_17. Online ahead of print. Asian J Androl. 2017. PMID: 29286005 Free PMC article. Review.
-
Radium-223 dichloride in clinical practice: a review.Eur J Nucl Med Mol Imaging. 2016 Sep;43(10):1896-909. doi: 10.1007/s00259-016-3386-5. Epub 2016 Apr 28. Eur J Nucl Med Mol Imaging. 2016. PMID: 27121689 Review.
References
-
- Ahmed K., Stauder M., Miller R., Bauer H., Rose P., Olivier K., et al. (2012) Stereotactic body radiation therapy in spinal metastases. Int J Radiat Oncol Biol Phys 82: e803–e809. - PubMed
-
- Amdur R., Bennett J., Olivier K., Wallace A., Morris C., Liu C., et al. (2009) A prospective, phase II study demonstrating the potential value and limitation of radiosurgery for spine metastases. Am J Clin Oncol 32: 515–520. - PubMed
-
- Bashir F., Parry J., Windsor P. (2008) Use of a modified hemi-body irradiation technique for metastatic carcinoma of the prostate: report of a 10-year experience. Clin Oncol (R Coll Radiol) 20: 591–598. - PubMed
-
- Ben-Josef E., Shamsa F., Williams A., Porter A. (1998) Radiotherapeutic management of osseous metastases: a survey of current patterns of care. Int J Radiat Oncol Biol Phys 40: 915–921. - PubMed
-
- Berg R., Yilmaz M., Hoyer M., Keldsen N., Nielsen O., Ewertz M. (2009) Half body irradiation of patients with multiple bone metastases: a phase II trial. Acta Oncol 48: 556–561. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources